Pituitary adenoma occurring with acromegaly coexisting with partially empty sella syndrome
Journal Title: OncoReview - Year 2015, Vol 5, Issue 4
Abstract
Pituitary microadenoma occurring with acromegaly coexisting with empty sella syndrome is a rare clinical case. The main symptoms result from the presence of hormonally active pituitary tumor. Empty sella syndrome may hinder correct and prompt diagnosis, which may be important for effective therapy. We present a case of a 67-year-old woman admitted to hospital with acromegaly. MRI of the pituitary revealed partially empty sella and pituitary microadenoma. The patient underwent surgery. Follow-up MRI revealed regression of the pituitary adenoma without signs of recurrence during observation. We also present a review of literature.
Authors and Affiliations
Tomasz Trybek, Aldona Kowalska
Keywords
Related Articles
- EP ID EP78728
- DOI 10.5604/20828691.1189744
- Views 218
- Downloads 0
Squamous cell oesophageal cancer in retinoblastoma survivor: does germinal RB1 mutation influence chemo- and radiosensitivity?
The case of complete response of squamous cell oesophageal cancer to radiochemotherapy in patient previously operated due to hereditary retinoblastoma is presented. Second cancers in retinoblastoma survivors are the main...
Zaburzenia psychiczne u chorych na nowotwory - podejście kliniczne
Pacjent z chorobą nowotworową nie tylko mierzy się z chorobą pierwotną, ale także narażony jest na stany emocjonalne, które przy niesprzyjających warunkach i dużym obciążeniu mogą prowadzić do depresji, zwiększonego lęku...
Cardiooncological balance in a 75-year-old male with a hepatocellular carcinoma CS IV and a congestive heart failure NYHA III „de novo”
The case reports about a 75-years-old man without a previous medical history, in whom a heart failure NYHA III de novo was diagnosed together with persistent atrial fibrillation and hepatocellular carcinoma in clinical s...
Everolimus-induced interstitial lung disease in patient with metastatic renal cell carcinoma – case report and literature review
We present a case of a 70-year-old man with metastatic renal cell carcinoma treated with second-line everolimus after rapid progression on first-line tyrosine kinase inhibitor, in whom a side effect of the therapy occurr...
Planning hormonal therapy in prostate cancer patients – expert view
In last decades prostate cancer became one of the most common cancers in the World, and one of the most common cancer death diagnosis. As a hormone-dependent entity for almost 70 years prostate cancer is treated with hor...